Recordati SpA (LTS:0KBS) 5-Year EBITDA Growth Rate : 5.60% (As of Sep. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Recordati SpA 5-Year EBITDA Growth Rate?

Recordati SpA's EBITDA per Share for the three months ended in Sep. 2024 was €1.00.

During the past 12 months, Recordati SpA's average EBITDA Per Share Growth Rate was 14.40% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 7.70% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 5.60% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 11.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Recordati SpA was 25.00% per year. The lowest was -1.40% per year. And the median was 10.85% per year.

Competitive Comparison of Recordati SpA's 5-Year EBITDA Growth Rate

For the Drug Manufacturers - General subindustry, Recordati SpA's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Recordati SpA's 5-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Recordati SpA's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Recordati SpA's 5-Year EBITDA Growth Rate falls into.

Recordati SpA 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Recordati SpA (LTS:0KBS) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Recordati SpA 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Recordati SpA's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Recordati SpA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Recordati SpA (LTS:0KBS) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

RICFY:USA REC:Italy RECm:UK RER1:Germany RER1:Germany REC:Austria

Address

Via Matteo Civitali 1, MIlan, ITA, 20148

Website

https://www.recordati.com

Recordati SpA is a drug manufacturing company that focuses on specialty pharmaceuticals. The company produces and promotes medicines globally that focus on primary-care therapies and rare diseases. Recordati uses strategic partnerships as part of its long-term growth. The vast majority of the company's revenue is generated in Italy, followed by the United States, France, and Germany. Recordati reports two operating segments: Specialty and Primary care and Rare diseases. The bulk of the company's profit is derived from its specialty and primary care segment which includes the production of active ingredients.

Recordati SpA Headlines

No Headlines